Biomarker Changes Associated With Both Dulaglutide and Cardiovascular Events in the REWIND Randomized Controlled Trial: A Nested Case-Control Post Hoc Analysis.

Hertzel C Gerstein,Shun-Fu Lee,Guillaume Paré,M Angelyn Bethel,Helen M Colhoun,Anastasia Hoover,Mark Lakshmanan,Yanzhu Lin, Valentino Pirro,Hui-Rong Qian,Giacomo Ruotolo,Lars Ryden,Jonathan M Wilson,Kevin L Duffin

Diabetes care（2023）

引用 1|浏览32

暂无评分

摘要

Dulaglutide was associated with a reduced 2-year rise from baseline of NT-proBNP and GDF-15. Higher rises of these biomarkers were also associated with MACE.

查看译文

关键词

biomarker changes associated,cardiovascular events,randomized controlled trial,dulaglutide,case-control

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要